Skip to main content
. 2020 Aug 26;11:2041731420943839. doi: 10.1177/2041731420943839

Table 1.

Comparison of clinical strategies with MSC-based therapies for cartilage damage treatment.

Strategy Advantage Disadvantage Reference
Distraction Increase joint space and reduce pressure in joint
Significant improvements in pain and mobility of joint
Technical simplicity
Low cost
Pin tract infection
Neuropraxia
Thrombosis
Mastbergen et al.6
Autologous osteochondral implantation Generally biocompatible in vivo
Improved the prognosis of large size osteochondral defect
Largely invasive
Graft separation
Daher et al.2
Allograft osteochondral implantation Maintain the original structure for repaired tissue Immune reaction
Display variability among different samples
Limited donor source
Daher et al.2
Autologous chondrocyte implantation Appropriate phenotype required for cartilage repair
Limited invasiveness
Avoid potential immune complications
Dedifferentiation to fibroblast-like cells in monolayer culture
Limited mitotic activity
Two-stage operation
Djouad et al.4
Joint replacement Metal prostheses provide excellent fracture resistance and mechanical strength
Ceramic prostheses showed great osteoconduction ability
Metal toxic degradation products and immunogenicity
Do not provide suitable microenvironment for tissue growth
Smith and Grande7
MSC-based therapies Regeneration of a relative complete, functional cartilage tissue
Can be modified and processed to desired specifications with consistent quality
Relatively good biocompatibility and similar biomechanical properties with the target tissue
Increased complexity for fabricating
Difficult to process in clinical practice
Zhu et al.63

MSC: mesenchymal stem cell.